KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours.
15 auth.
M. Debiec-Rychter,
R. Sciot,
A. Le Cesne,
M. Schlemmer,
P. Hohenberger,
A. V. van Oosterom,
J. Blay,
S. Leyvraz,
M. Stul,
P. Casali,
...
J. Zalcberg,
J. Verweij,
M. V. Van Glabbeke,
A. Hagemeijer,
I. Judson
|
|
9 |
2006 |
Social Media Posts